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Quantitative RT-PCRhogenetic potential of human parvovirus B19 requires the deﬁnition of the
complete spectrum of cellular tropism and a functional analysis of the viral genome in infected cells. In this
study, we carried out a systematic functional analysis of B19 virus genome in the course of infection of
susceptible bone marrow mononuclear cells and myeloblastoid UT7/EpoS1 cells, in terms of dynamics of
nucleic acid synthesis. A PCR array was designed and a comprehensive analysis was performed by
quantitative PCR and RT-PCR, yielding extended information on the presence and abundance of the diverse
classes of viral nucleic acids, on the temporal regulation of genome expression and on its relationship with
the cell cycle. The analysis performed indicate that the synthesis of viral nucleic acids is correlated to the
progression through the S phase of the cell cycle, that an extended pattern of transcriptional activity occurs
throughout the course of infection, with a maximal rate of transcription preceding the onset of S-phase
dependent replication of the viral genome, and that utilization of transcript processing signals is relatively
constant throughout the course of infection. The information obtained led to the deﬁnition of a uniﬁed model
of functional and expression proﬁling of parvovirus B19 genome.
© 2008 Elsevier Inc. All rights reserved.IntroductionHuman Parvovirus B19, member of the Erythrovirus genus in the
Parvoviridae family, is a widespread human pathogenic virus that
can be associated with an ample range of pathologies and clinical
manifestations (Young and Brown, 2004). Structural features of B19
virus are typical of viruses in the family. One molecule of linear single-
stranded DNA of either positive or negative polarity, about 5600 bases
in length, is encapsidated in isometric virions, approximately 22 nm in
diameter. The viral genome is composed of a unique internal region,
containing all the coding sequences, ﬂanked by two repeated inverted
terminal regions (Fig. 1). Two major open reading frames (ORF) are
present in the viral genome. In the left half of the genome, an ORF
(frame 3) codes for the non-structural protein NS; in the right half of
the genome, an ORF (frame 1) codes for both viral capsid proteins VP1
and VP2. Two minor ORFs are present (frame 2), overlapping with the
major ORFs at the centre and at the right end of the genome, coding
respectively for a putative 9 kDa protein and an 11 kDa protein. An
additional ORF is present (frame 1), coding for a 7.5 kDa protein.
According to the accepted model of replication of the viral genome
(Ozawa et al., 1986), the inverted terminal regions are able to fold intoella).
nstitute, University of Helsinki,
l rights reserved.hairpin structures that function as origins of replication by priming
the conversion of the single-stranded parental template into a double-
stranded replicative intermediate; resolution of the terminal hairpins
can then occur, operated by the viral non-structural protein, followed
by separation of the single stranded replicative products. Expression
of the viral genome is driven by a single promoter and is regulated by
co- or post-transcriptional processing of RNA (Ozawa et al., 1987a;
Yoto et al., 2006). Initiation of transcription occurs at a single site
proximal to the left terminal region; processing of RNA includes two
distinct and sequential splicing events, each deﬁned by a single donor
and two alternative acceptor sites; termination of transcription and
cleavage-polyadenylation occur either at a central position, deﬁned by
two alternative sites, or at a distal position, deﬁned by a single
terminal site proximal to the right terminal region. The different
combinations of events and utilization of processing signals result in
the production of the whole set of different viral mRNAs that can be
translated into the viral non-structural and structural proteins (Ozawa
and Young, 1987).
Comprehension of the pathogenetic potential of B19 virus requires
the deﬁnition of the complete spectrum of cellular tropism and a
functional analysis of the viral genome in infected cells. Viral
replication and expression are still incompletely described in terms
of dynamics and molecular interactions within the cellular environ-
ment. Infection of susceptible target cells typically gives rise to a
restrictive pattern of infection. It is assumed that viral replication is
restricted at the S phase of the cellular cycle and strongly depends on
Fig. 1. Outline of parvovirus B19 genome structure and organization. The functional map of B19 virus genome is derived from (Ozawa et al., 1987a; Yoto et al., 2006) and from data
obtained in this study.
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relevance still await to be investigated. In erythroid progenitor cells
and in somemyeloblastoid cell lines, e.g., UT7/Epo and KU812Ep6, the
virus can complete a productive replicative cycle (Ozawa et al., 1987b;
Shimomura et al., 1992; Miyagawa et al., 1999). In different cell types,
such as megakaryoblasts (Srivastava et al., 1990) and other myelo-
blastoid cell lines (Munshi et al., 1993; Gallinella et al., 2000), the virus
may not achieve a productive replicative cycle. Several studies have
proposed many diverse mechanisms of regulation (Liu et al., 1991a,
1991b, 1992; Shimomura et al., 1993; Pallier et al., 1997; Brunstein et
al., 2000; Gallinella et al., 2000) operating at different stages of the
replicative cycle. Quantitative analysis of B19 virus genome replication
and expression following in vitro infection experiments indicates that
B19 virus genome operates as a single, two-state functional unit
(Bonvicini et al., 2006). According to this model, a main restrictive
event can be identiﬁed in the conversion of the single-stranded
parental template into a double-stranded, functionally active tem-
plate. Then, DNA replication, RNA transcription and co- and post-
transcriptional processing of RNA can occur as a unique and
coordinated set of events.
In this study, we sought to obtain a systematic functional analysis
of B19 virus genome in the course of infection of susceptible bone
marrow mononuclear cells and myeloblastoid UT7/EpoS1 cells, in
terms of dynamics of nucleic acid synthesis. For this purpose, a PCR
array was designed and a comprehensive analysis was performed by
quantitative PCR and RT-PCR, yielding extended information on the
presence and abundance of the diverse classes of viral nucleic acids.
PCR arrays are commonly developed for the analysis of cellular
expression proﬁles, and this study shows that this experimental
approach can be effectively applied to a thorough analysis of a viral
expression proﬁle. The information obtained led to the deﬁnition of auniﬁed model of functional and expression proﬁling of B19 virus
genome.
Results
Design of a PCR array
A systematic functional analysis of B19 virus genome was sought
by the design of a PCR array for quantitative PCR and RT-PCR analysis
(Table 1), speciﬁcally planned to include all the diverse classes of viral
nucleic acids (Fig. 2). Oligonucleotide primers were selected on the
basis of the known functional map of B19 virus genome, as
complementary either to a contiguous sequence, positioned in a
deﬁned exon or intron, or to a non-contiguous sequence, correspond-
ing to a deﬁned splice junction. Combinations of primers were
optimized in order to discriminate all the different subsets of the viral
nucleic acids on the basis of splice deﬁnition and exon/intron
composition.
The speciﬁcity and selectivity of the different primer combinations
were tested by ampliﬁcation of in vitro synthesized DNA and RNA
targets, corresponding to the complete internal coding sequence of
B19 virus genome, and of DNA and RNA extracted from reference
infected and uninfected bone marrow and UT7/EpoS1 cell samples.
PCR and RT-PCR products were analyzed by melting proﬁle and by
agarose gel electrophoresis, conﬁrming that all ampliﬁcation reactions
exclusively yielded the expected ampliﬁcation products. The perfor-
mance of the quantitative PCR and RT-PCR reactions was evaluated on
the basis of the analytical characteristics of standard curves obtained.
For all primer pairs tested, these yielded a linear range of quantitative
evaluation within 103–108 target copies, with R2 values constantly
N0.99 and average variability in quantitation b6% (0–20%).
Table 1
Primers and primer combinations used in the PCR array for the detection and quantitative evaluation of B19 virus nucleic acids
Primer Sense Primer Antisense DNA target
R2210 CGCCTGGAACACTGAAACCC R2355 GAAACTGGTCTGCCAAAGGT Virus DNA
EC014 TATTTCTCCTGCTACTTGTC EC184 CCTCGTCATCTTGCTGGTGA EC01 DNA
Primer Sense Primer Antisense RNA Target
R0534 TGGGCTGCTTTTTCCTGGAC R0622 ATAGCTCCATGTTAGTATGT 01/a
R2101⁎ CTGGGTGGAGGGCATCTGTT 02/a, 04, 06, 08
R2221⁎ CAGTGTTCCAGGCGCCTGTT 03/a, 05, 07, 09
R1882 GCGGGAACACTACAACAACT R2033 GTCCCAGCTTTGTGCATTAC 01/a
R2210 CGCCTGGAACACTGAAACCC R2355 GAAACTGGTCTGCCAAAGGT 01/a – 09
R2182 GCAGCTTTTTTAACCTCATC R2377 TCAACCCCAACTAACAGTTC 01/a, 02/a, 04
R3238⁎ CAGGGGCAGCTGCACAGTTC 06
R4897⁎ GTTTTGCATCTGTAGAGTTC 08
R2210 CGCCTGGAACACTGAAACCC R2377 TCAACCCCAACTAACAGTTC 01/a, 02/a, 03/a, 04, 05
R3238⁎ CAGGGGCAGCTGCACAGTTC 06, 07
R4897⁎ GTTTTGCATCTGTAGAGTTC 08, 09
R2998 CCCGGTACTAACTATGTTGG R3103 CCAGTTGGCTATACCTAAAG 01a, 02a, 03a, 04, 05
R3153 CTCTTCATCTGCTACAGTCC 04, 05
R3180 TGGGTTTCAAGCACAAGTAG R3342 TGCACCAGTGCTGGCTTCTG 04, 05
R3224⁎ CAGTTTCGTGAACTGTGCAG 06, 07
R4883 ATATGACCCCACAGCTACAG R5014 TGGGCGTTTAGTTACGCATC 06, 07
R4883⁎ CAGTTTCGTGAACTCTACAG 08, 09
R4883⁎⁎ TGAGCTAACTAACAGCTACA 10
R4899 ACACCACAGGCATGGATACG R5014 TGGGCGTTTAGTTACGCATC 06, 07, 08, 09, 10
Sequence of primers is derived from reference genome sequence NC_000883, as complementary either to a contiguous sequence or to a non-contiguous sequence. In primersmarked
with ⁎, bases on the 5′ end are complementary to bases on the external side of a splice site, whereas 5–6 bases on the 3′ end (shown in italics) are complementary to bases on the
internal side of a splice site. RNA target is deﬁned with respect to the functional map of B19 virus genome.
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RT-PCR in order to obtain a comprehensive quantitative analysis of the
expression proﬁle of B19 virus genome in the course of infection of
susceptible bone marrow mononuclear cells and myeloblastoid UT7/
EpoS1 cells. For each experimental sample, it could be determined the
amount of viral DNA, the amount of total viral RNA and, speciﬁcally,
the relative amount of the different subsets of viral RNA as arising
from the differential processing of viral RNA. Quantitation of viral DNA
was obtained as an absolute quantitation, by interpolation on
standard curves and normalization by the respective quantitation of
EC01 DNA as reference target. Quantitation of total viral RNA was
similarly obtained as an absolute quantitation, by interpolation on
standard curves and normalization by the respective quantitation of
EC01 RNA, while quantitation of the different subsets of viral RNAwas
obtained as a comparative quantitation, normalized to the amount of
total viral RNA.
Usage of the ﬁrst splice donor (D1) and selection of the ﬁrst splice
acceptor (A1-1/2) could be analyzed by combining primer R0534
(common primer positioned in the leader region) with either primerFig. 2. Position of primers used in the PCR array (see also Table 1) with respect to B19 virus g
their distributionwith respect to the functional map of B19 virus genome. Sense primer R053
D1 site, antisense primers R2101⁎ and R2221⁎ are respectively complementary to splice ju
between D1 and A1-1 sites. Sense primer R2182 is positioned between A1-1 and A1-2 sites, a
and R2377 are respectively positioned upstream or in correspondence to D2 site. Antisense p
or D2/A2-2. Sense primer R2998 is positioned between pAp1 and pAp2 sites, antisense prim
Sense primers R3180 and R3224⁎ are respectively positioned upstream of A2-1 site or compl
of A2-1 site. Sense primers R4883, R4883⁎ and R4883⁎⁎ are respectively positioned in corresp
primer R4899 and antisense primer R5014 are positioned in the region between A2-2 andR0622 (speciﬁc for unspliced transcripts: 01 and 01a), R2101⁎ (speciﬁc
for the proximal ﬁrst acceptor site: 02, 02a, 04, 06, and 08) or R2221⁎
(speciﬁc for the distal ﬁrst acceptor site: 03, 03a, 05, 07, and 09).
Unspliced transcripts (01 and 01a) could be selectively ampliﬁed by
the primer pair R1882–R2033, while the primer pair R2210–R2355,
being located in the central exon, could amplify thewhole ensemble of
viral transcripts and therefore was chosen for the calibrator reaction.
Usage of the second splice donor (D2) and selection of the second
splice acceptor (A2-1/2) could be analyzed by combining primer
R2182 (common primer positioned between sites A1-1 and A1-2) or
R2210 (common primer positioned in the central exon) with either
primer R2377 (speciﬁc for unspliced transcripts: 01, 01a, 02, 02a, 03,
03a, 04, and 05), R3238⁎ (speciﬁc for the proximal second acceptor
site: 06 and 07) or R4897⁎ (speciﬁc for the distal second acceptor site:
08, 09). Comparison among the different sets of primer pairs allowed
discrimination of the relative contribution of the products of the ﬁrst
splicing event to the second splicing event. Usage of the proximal
acceptor site in the second splicing event could be analyzed by
combining primer R3342 with either primer R3180 (speciﬁc forenome. The selectivity of primer pairs in the ampliﬁcation of speciﬁc targets is linked to
4 is positioned upstream of D1 site, antisense primer R0622 is positioned downstream of
nctions D1/A1-1 and D1/A1-2. Primers R1882 and R2033 are positioned in the region
nd sense primer R2210 is positioned downstream of A1-2 site. Antisense primers R2355
rimers R3238⁎ and R4897⁎ are respectively complementary to splice junctions D2/A2-1
er R3103 is positioned upstream and antisense primer R3153 downstream of pAp2 site.
ementary to D2/A2-1 splice junction, antisense primer R3342 is positioned downstream
ondence of A2-2 site, or complementary to D2/A2-2 and D1/A2-2 splice junctions. Sense
pAd sites.
171F. Bonvicini et al. / Virology 381 (2008) 168–177unspliced transcripts: 01, 01a, 02, 02a, 03, 03a, 04, and 05) or R3224⁎
(speciﬁc for the proximal second acceptor site: 06 and 07). Usage of
the distal acceptor site in the second splicing event could be analyzed
by combining primer R5014 with either primer R4883 (speciﬁc for
unspliced transcripts: 01, 01a, 02, 02a, 03, 03a, 04, 05, 06, and 07) or
R4883⁎ (speciﬁc for the distal second acceptor site: 08 and 09). Usage
of the proximal and distal cleavage-polyadenylation signals could be
analyzed by the primer pairs R2210–R2377 (upstream of pAp1: 01,
01a, 02, 02a, 03, 03a, 04, and 05), R2998–R3103 (upstream of pAp2:
01a, 02a, 03a, 04, and 05), R2998–R3153 (readthrough of pAp: 04 and
05), R4899–R5014 (upstream of pAd: 06, 07, 08, and 09).Fig. 3. B19 virus infection of bone marrow mononuclear cells. Amounts of viral DNA and tota
viral RNA are expressed as fractional values of total viral RNA.The possibility of alternative splicing patterns with respect to the
known transcription map of B19 virus genome was also investigated.
By using further combinations of primers, it was not possible to detect
any unusual splicing of the leader region to the central common exon.
When examining the possibility of direct splicing of the leader region
to a distal exon, without splicing to the central common exon, it was
not possible to detect any splicing of D1 donor to the A2-1 acceptor
site, while it was detected a direct splicing of D1 donor to the A2-2
acceptor site. This splicing patternwas conﬁrmed by sequencing of RT-
PCR products, and therefore a novel RNA species (transcript 10) was
added to the revised transcription map of B19 virus.l viral RNA are expressed as relative values per cell; amounts of the different subsets of
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The estimates on the abundance of the diverse classes of viral
nucleic acids in the course of infection of bone marrow mononuclear
cells are shown in Fig. 3 for a representative experiment. Viral DNA
steadily increased from 2 to 24 hpi (+1.7 Log) and from 24 to 48 hpi
(+1.9 Log). Viral RNA increased from 2 to 24 hpi (+4.0 Log) and
decreased from 24 to 48 hpi (−2.5 Log). Therefore, viral RNA/DNA ratio
increased from 2 to 24 hpi (+2.3 Log) and decreased from 24 to 48 hpi
(−4.3 Log), indicating an early phase of maximal transcriptional
activity compared to replicative activity of viral DNA.
The expression proﬁle of the viral genome was determined on the
basis of the relative abundance of the different subsets of viral RNA.
Transcriptional activity was already detectable at 2 hpi. At early times
in the course of infection, the low amounts of total RNA did not allow
to obtain an accurate quantitation of the different RNA species;
however, detection of most of the RNA targets indicated the early
onset of the full transcriptional programme of B19 virus genome. At
later times in the course of infection, from 24 to 48 hpi, the increased
amounts of total RNA allowed to determine with higher accuracy the
relative abundance of the different RNA species as originated from
RNA processing. The data obtained indicated a stable expression
proﬁle, as all RNA species were detected throughout the time course of
infection and only minor differences were observed in the frequency
of utilization of RNA processing signals.
Investigation on the usage of D1 and A1-1/2 splice sites and on the
relative abundance of unspliced or spliced RNA species showed an
abundance of 1–7% for unspliced RNA (row 1), compared to 93–99%
for spliced RNA (rows 2 plus 3), and an equivalent usage of the
proximal or distal acceptor sites. Direct comparison of the abundance
of unspliced RNA (row 4) relative to the amount of total viral RNA (row
5) yielded a similar estimate.
Investigation on the usage of D2 and A2-1/2 splice sites and on the
relative abundance of unspliced/single spliced or double spliced RNA
species showed a balanced amount of unspliced/single spliced (row 9)
or double spliced RNA (rows 10 plus 11), 42–56% compared to 44–58%.
In particular, usage of the proximal acceptor site in the ﬁrst splicing
event led to a high and constant prevalence of single spliced RNA
(rows 6 to 8), while usage of the distal acceptor site accounted for
most of the double spliced RNA.
For unspliced/single spliced RNA species, cleavage at pAp1 site
occurred at a 61–70% frequency (compare rows 12 and 13), leading to
an estimate of 14–18% for the abundance of pAp1 readthrough
transcripts. Further cleavage at pAp2 site occurred at a 72–94%
frequency (compare rows 13 and 14), leading to an estimate of 1–5%
for the abundance of pAp2 readthrough transcripts.Fig. 4. Distribution of UT7/EpoS1 cells among different phases of the cell cycle as determine
medium (−64 hpi), after culturing in minimal medium for 48 h (−16 hpi), after culturing eith
different time points (2–48 hpi) in the course of infection.For double spliced RNA species, usage of acceptor site A2-1 (row
10) was prevalent over usage of A2-2 (row 11), however decreasing
throughout the time course of infection. This led to an abundance of
31–50% of RNA spliced to the proximal second acceptor site and of 8–
16% of RNA spliced to the distal second acceptor site. Concordant
values were obtained by investigating the relative abundance of
contiguous or spliced transcripts to a same distal exon (compare rows
15 and 16 to rows 17 to 19). The RNA arising from direct splicing of the
leader sequence to the A2-2 acceptor site was detected only in trace
amounts (row 20). The overall amount of RNA cleaved to the pAd site
was therefore 45–60% of total viral RNA.
Infection of myeloblastoid cells
Bone marrow mononuclear cells are a heterogeneous population,
consisting of different cell types at different stages of differentiation
and at different phases of the cell cycle. The myeloblastoid UT7/EpoS1
cells offer the advantage of a more homogeneous population, where
also a partial synchronization can be achieved. Infection of UT7/EpoS1
cells as model system was therefore considered suitable for studying
any possible relationship between the phase of cell cycle and the
replication and expression patterns of B19 virus.
UT7/EpoS1 cells were cultured in minimal medium for 48 h, and
then either in the absence (Aph−) or presence (Aph+) of aphidicolin
for 16 h. Infection was carried out at the time of release from the cell
cycle block, then cell samples were analyzed at different time points
post-infection and characterized for both cellular progression through
the cell cycle and viral replication and expression. The degree of
synchronization achieved was only partial and measurable in terms of
variation of distribution of DNA content within the cell population
(Fig. 4). The effect of the presence of aphidicolin was evident as a
relative depletion of cells in S phase at 0–2 h post-release, followed by
a relevant enrichment in cells in S phase at 6 h, while at later times the
distribution of cells among the different phases of the cell cycle was
relatively unaffected.
The estimates on the abundance of the diverse classes of viral
nucleic acids in the course of infection of UT7/EpoS1 cells are shown in
Figs. 5 and 6 for a representative experiment. In Aph− cells, the
amount of viral DNA was constant between 18 and 24 hpi (−0.1 Log),
then increased between 24 and 36 hpi (+1.3 Log) and between 36 and
48 hpi (+0.6 Log). The amount of viral RNA increased between 18 and
24 hpi (+1.3 Log) and between 24 and 36 hpi (+1.3 Log) but not
between 36 and 48 hpi (+0.1 Log). Therefore, viral RNA/DNA ratio
increased between 18 and 24 hpi (+1.4 Log), was constant between 24
and 36 hpi (0.0 Log) and decreased between 36 and 48 hpi (−0.5 Log).
In Aph+ cells, the overall rate of viral nucleic acids synthesis was lower,d by FACS analysis. UT7/EpoS1 cell samples were analyzed before culturing in minimal
er in the absence (Aph−) or presence (Aph+) of aphidicolin for 16 h (0 hpi) and then at
Fig. 5. B19 virus infection of UT7/EpoS1 (Aph−) cells. Amounts of viral DNA and total viral RNA are expressed as relative values per cell; amounts of the different subsets of viral RNA
are expressed as fractional values of total viral RNA.
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Altogether, these data indicate a dependence of viral nucleic acid
synthesis on the phase of cell cycle at the start of infection, as a lower
fraction of cells in S phase correlates with lower rates of viral nucleic
acids synthesis. Then, an early phase of transcriptional activity can
occur preceding the onset of the replicative activity of viral DNA,
linked to the progression through the cell cycle within the time frame
analyzed.
For both Aph− and Aph+ cell populations, transcriptional activity
was detected from 6 hpi; however, only at later times in the course of
infection, from 18 to 48 hpi, the amount of total RNA allowed to
determine the relative abundance of the different RNA species as aresult of RNA processing. A distinct expression proﬁle of the viral
genome was observed at early (18 hpi) compared to later (24–48 hpi)
times in the course of infection.
Investigation on the usage of D1 and A-1/2 splice sites showed a
relatively higher abundance of unspliced RNA species at early times
post-infection, together with a prevalent usage of the distal compared
to the proximal splice acceptor sites. Investigation on the usage of D2
and A2-1/2 splice sites and on the relative abundance of unspliced/
single spliced or double spliced RNA species showed a marked shift in
the expression pattern. Unspliced/single spliced RNA accounted for
almost the totality of viral RNA at 18 hpi, whereas a comparable
amount of double spliced RNA was observed at 24–48 hpi. Usage of
Fig. 6. B19 virus infection of UT7/EpoS1 (Aph+) cells. Amounts of viral DNA and total viral RNA are expressed as relative values per cell; amounts of the different subsets of viral RNA
are expressed as fractional values of total viral RNA.
174 F. Bonvicini et al. / Virology 381 (2008) 168–177A1-1 acceptor site in the ﬁrst splicing event was linked to a high and
constant prevalence of single spliced RNA, while usage of the A1-2
acceptor site accounted for most of the double spliced RNA. For
unspliced/single spliced RNA, cleavage at pAp1 site occurred at a
higher frequency at early times, while frequency of cleavage at pAp2
site increased at later times post-infection. For double spliced RNA,
usage of the acceptor site A2-1 was comparable to usage of A2-2. This
led to a balanced ﬁnal abundance of RNA spliced to the proximal
second acceptor site and of RNA spliced to the distal second acceptor
site. Therefore, the overall amount of RNA cleaved to the pAd site
increased from minimal levels at early times to high levels at later
times in the course of infection.Discussion
In this study, a systematic functional analysis and deﬁnition of the
expression proﬁle of B19 virus genome in the course of infection of
susceptible bone marrow mononuclear and UT7/EpoS1 cells were
obtained by use of a PCR array and quantitative PCR and RT-PCR
analysis. In a previous study (Bonvicini et al., 2006), the use of
quantitative PCR and RT-PCR for the selective ampliﬁcation of
different regions of the viral genome could only yield information
on the relative abundance of expression from different genomic
regions. As a further reﬁnement of such experimental approach, the
development and application of a PCR array have made it possible to
175F. Bonvicini et al. / Virology 381 (2008) 168–177investigate the presence and abundance of all the diverse classes of
viral nucleic acids. This study shows how an experimental approach
based on a PCR array can be effectively applied to a comprehensive
analysis of a viral expression proﬁle. In our experimental setting, the
results obtained led to the deﬁnition of a uniﬁed model of functional
and expression proﬁling of B19 virus genome.
The compact and complex organization of B19 virus genome poses
however a challenging problem. Detection and quantitation of viral
DNA and total viral RNA as single targets are straightforward
processes, whereas deﬁnition of the abundance of the different
subsets of viral RNA poses the necessity to obtain a balanced
quantitation of multiple targets, all of which are part of a unique
ensemble. The fact that all subsets of viral RNA originate from a
limited genomic region adds a level of complexity that needs to be
solved by designing a redundant PCR array, with different primers
positioned on selected regions of the viral genome and different
combinations of primers optimized to select speciﬁc subsets of
targets. In our experimental approach, total RNA would contribute
to quantitation of targets at any stage of processing of transcripts,
including incompletely processed as well as mature messengers.
Hence, our results should be interpreted in terms of deﬁnition of
frequency of utilization of RNA processing signals. The level of
resolution attained by the PCR array could allow to determine the
frequency of utilization of each RNA processing signal, and conse-
quently to infer an estimate of the abundance of the different subsets
of viral RNA species. However, deﬁnite RNA species might not all be
distinguishable by this approach: in particular, it will not be possible
to discriminate the RNA species differing only on the utilization of
pAp1/2 sites.
Several different algorithms for the determination of nucleic acid
abundance by means of quantitative PCR and RT-PCR have been
proposed (Kubista et al., 2006). In our model system, functional
analysis of B19 virus genome throughout the time course of infection
requires to obtain quantitation of the abundance of multiple targets
within each experimental sample, coupled to a comparison of
quantitative values among different samples representative of a
time course of infection. Therefore, quantitation of viral nucleic
acids was carried out by using two different algorithms. Absolute
quantitation by interpolation on standard curves, possible only for
contiguous primer pairs, was performed for quantitative evaluation of
total viral DNA and RNA and yielded information on viral replication
and expression in the course of infection. Comparative quantitation by
calibration to total viral RNA, possible for both contiguous and non-
contiguous primer pairs, was performed for the deﬁnition of a matrix
of fractional values for all speciﬁc subsets of viral RNA targets and
yielded information on the pattern of expression at selected time
points in the course of infection. It should always be stressed that our
experimental approach yielded information on average values within
a heterogeneous cell population, and that quantitative results can only
be interpreted in terms of variation of the relative abundance of
different nucleic acid species.
Within the limits posed by the experimental setting and the
analytical procedure followed, our results yielded extensive informa-
tion on the temporal regulation of genome expression and its
relationship with the cell cycle. The dependence of B19 virus
replication on cellular S phase is assumed because of the general
biology of the Parvoviridae family, but it has not been thoroughly
investigated. Although the heterogeneous bone marrow cells do not
allow to draw conclusions on the relationship between viral
macromolecular synthesis and cellular cycle, observations on UT7/
EpoS1 cells partially synchronized by the use of aphidicolin as a DNA
polymerase inhibitor, which block cells at early S phase, conﬁrm that
viral synthesis are correlated to progression through the S phase of the
cell cycle. A ﬁrst step in macromolecular synthesis of the viral
replicative cycle is the conversion of the incoming single-stranded in a
double-stranded molecule, in order that the viral genome can starttranscriptional and replicative activity (Gallinella et al., 2000;
Bonvicini et al., 2006). The analytical performance of quantitative
PCR does not allow discrimination between the two forms, never-
theless our data suggest that synthesis of the complementary strand
may be critically dependent on the S phase of the cell cycle and can
therefore be considered a crucial restrictive event in the viral cycle.
Following this step, an extended pattern of transcriptional activity can
constantly be present from immediate early times throughout the
course of infection, with a maximal rate of transcription preceding the
onset of S-phase dependent replication of the viral genome. The
reciprocal relationship between B19 virus and cell cycle may however
be more complex, as the virus can block the progression through the
cell cycle and induce apoptosis (Morita et al., 2001, 2003).
Our study also indicates the presence of differences in genome
expression among different cell types. Transcriptional activity
depends on cis-elements in the single P6 promoter, and on interaction
of basic transcriptional machinery with cellular factors and viral NS
protein (Raab et al., 2001, 2002). Replicative activity similarly depends
on integrity of the terminal hairpins as origins of replication and rely
on viral NS protein in addition to cellular machinery (Zhi et al., 2006).
Transcriptional activity, as determined by RNA/DNA ratio, appeared to
be stronger in bone marrow cells than in UT7/EpoS1 cells, while the
difference between cell types was less pronounced in terms of
replicative activity of viral DNA.
The presence and utilization of splicing and cleavage-polyadenyla-
tion signals determine the relative abundance of the different RNA
species originating from a single and compact transcriptional unit.
Utilization of the processing signals emerged to be relatively constant
throughout the viral infection cycle, with the only relevant exception
of the difference observed at early compared to later times post-
infection in UT7/EpoS1 cells. In these cells it was observed an overall
reduced rate of splicing both of the ﬁrst and, to a high extent, of the
second intron, in the presence of a constant utilization of the pAp1/2
cleavage sites. It might therefore be possible to indicate an early
modulation in expression proﬁling of the viral genome, linked to
transition from a low splicing, prevalent pAp cleavage to a high
splicing, balanced pAp/pAd cleavage.
A further regulated event appears to be the differential relative
utilization of splice acceptors A1-1/2 or A2-1/2, with differences
emerging between bone marrow or UT7/EpoS1 cells. For A1-1/2
acceptor sites, a balanced utilization is observed in bone marrow cells
compared to a prevalent utilization of A1-2 over A1-1 site in UT7/
EpoS1 cells. For A2-1/2 acceptor sites, a prevalent utilization of A2-1
over A2-2 is observed in BM cells compared to a balanced utilization in
UT7/EpoS1 cells. Finally, deﬁnition of the ﬁrst splice acceptor seems to
inﬂuence the frequency of utilization of the second splice donor, and
consequently the relative utilization of the proximal or distal
cleavage-polyadenylation signals.
The information obtained on viral expression proﬁle should be
considered in comparison towhat is the current paradigmon B19 virus
expression. Earlier data on expression of B19 virus genome, in fact,
suggested the presence of distinct early and late expression patterns
linked to viral genome replication and that deﬁnition of cleavage
would be of importance to determine the expression proﬁling of the
viral genome in permissive or non-permissive cell systems (Shimo-
mura et al., 1993). However, any regulation does not seem to be strictly
related to replication, as a steady transcription pattern is settled before
the onset of a constantly detected genome replication, and it should be
stressed that the regulated event appears to be splicing deﬁnitionmore
than cleavage signal utilization. Our previous data (Bonvicini et al.,
2006) suggested that B19 virus genome should be considered a single
replicative and transcriptional unit. The innovative analytical method
employed in the present study could add extended information and
yield an accurate measurement at the level of the diverse classes of
viral nucleic acids. The analysis performed conﬁrm and further reﬁne
such single-unit model, demonstrating the presence of a coordinated
176 F. Bonvicini et al. / Virology 381 (2008) 168–177set of events involved in DNA replication, RNA transcription and co-
and post-transcriptional processing of RNA. The discrepancy emerging
between data obtained by our quantitative analysis and previous data
reported in the literature can be attributed to differences in the
experimental designs and to the high resolution and analytical
performance of quantitative PCR and RT-PCR assays. As a note of
caution, as the determined amounts of viral nucleic acids are averaged
over the entire cell population, our data cannot exclude that different
patterns of expression might co-exist within a heterogeneous cell
population characterized by different cellular environments.
As a ﬁnal consideration, the RNA complement is only indicative of
the potential viral proteome. In fact, the transcription map has to be
reconsidered in viewof the presence of a-,mono- or bicistronicmRNAs,
and of the effective efﬁciency of translation of each ORF. In particular,
apart from the major ORFs in frame 3, coding for NS protein, and in
frame1 coding for VP1/2proteins, theminorORFs potentially coding for
lowMr proteins are still to be fully characterized (St Amand et al., 1991;
Luo and Astell, 1993). In frame 2, both ORFs in themiddle and right end
of the genome have similar topographical relation with respect to
transcripts, however evidence for translation of the middle ORF in a
putative 9 kDa protein is lacking, while translation of the right end ORF
gives rise to a 11 kDa protein, essential for viral infectivity. Similarly,
evidence of translation of the small ORF positioned in frame 1 ahead of
the ORF for VP proteins, coding for 7.5 kDa protein, is incomplete. In the
future, a proteomic analysis approach will be required for characteriza-
tion of the dynamics and interactions of viral proteins produced in
infected cells, and of virus-induced cellular alterations.
Materials and methods
Cells
Bone marrow mononuclear cells from normal volunteer donors
were obtained as frozen stocks from Cambrex. Cells were cultured in
IMDM, 10% FCS, 10 ng/ml IL-3 (Genzyme) and 10 U/ml Epo
(NeoRecormon, Roche), at 37 °C and 5% CO2, at an initial density of
1×106 cells/ml. After 2 days, non-adherent cells were recovered and
used for the infection experiments.
UT7/EpoS1 cells (a kind gift of K. Sugamura) were cultured in RPMI,
10% FCS and 2 U/ml Epo, at 37 °C and 5% CO2, at densities between
2×105–1×106 cells/ml. For synchronization, cells were cultured in
RPMI, 20 mM Hepes, 0.5% FCS and 2 U/ml Epo for 48 h, at an initial
density of 3×105 cells/ml, then either in the presence or absence of
2 μg/ml aphidicolin (Sigma) for 16 h. Cells were then washed,
recovered and used for the infection experiments by culturing in
complete medium for up to 48 h. Cell populations were analyzed by PI
staining (Nusse et al., 1990) and FACS analysis (Bryte HS, by Modﬁt
software, BioRad) for determination of the distribution of cells among
different phases of the cell cycle.
Virus and infection
A viremic serum sample, identiﬁed in our laboratory in the course
of routine diagnostic analysis, was used as source of virus for the
infection experiments. The viremic serum contained 1012 B19 virus
genome equivalents (geq)/ml, as determined by quantitative PCR
analysis (Gallinella et al., 2004), and did not contain anti-B19 speciﬁc
IgM or IgG antibodies detectable by commercial ELISA tests (Biotrin).
For infection, cells were incubated at a density of 106 cells/ml in
minimal medium in the presence of 10−3 volume of viremic serum, in
order to obtain amultiplicity of infection (moi) of 103 geq/cell. Following
adsorption for 2 h at 37 °C, the inoculumvirus waswashed and the cells
were incubated at 37 °C in complete medium at an initial density of
1×106 cells/ml. Constant volumes of cell cultures, corresponding to
0.5 ml of the initial cell culture volume, were collected at different time
points post-infection (hpi) for nucleic acid puriﬁcation and analysis.Productive infectionwas ascertained by immunoﬂuorescence detection
of viral NS protein (by amonoclonal human antibodyagainst NS protein,
kind gift of S. Modrow) and VP proteins (by a monoclonal mouse
antibody against VP1 and VP2 proteins, MAB8293, Chemicon).
Nucleic acid puriﬁcation
For nucleic acid puriﬁcation, cell culture samples were processed
both by using the MagNA Pure instrument and the MagNA Pure Total
Nucleic Acid Isolation Kit (Roche), in order to obtain a total nucleic acid
fraction, and by using the ToTally RNA puriﬁcation kit (Ambion)
following themanufacturer's protocol, in order to obtain a nucleic acid
fraction enriched in RNA.
PCR analysis
Standards and primers
Standard targets for the ampliﬁcation reactions were obtained
from plasmids pHR0 and pEC01 (Gallinella et al., 2004). Plasmid pHR0
contains an insert corresponding to the full internal region of B19
virus genome (nt. 345–5245). Plasmid pEC01 contains as insert a
synthetic sequence, unrelated to other natural sequences present in
the NCBI Nucleotide Database. In vitro synthesized DNA and RNAwere
quantiﬁed by spectrophotometric analysis and used as copy number
standards in the ampliﬁcation reactions. In the case of pEC01, in vitro
synthesized DNA and RNA were added at 109 geq/ml to the sample
lysis buffer in the nucleic acid puriﬁcation procedure and so copuriﬁed
with sample DNA and RNA as analytical control reagents and as
reference targets in the ampliﬁcation reactions.
PCR primers were speciﬁcally designed by using Clone Manager
8.0 software (Scientiﬁc & Educational Software), based on sequence
NC_000883 in the NCBI Genome Database as reference sequence, and
were obtained from MWG Biotech. Name, position, sequence and
target speciﬁcity of the designed primers are described in Table 1.
Oligonucleotide primers were designed on the basis of the known
functional map of B19 virus genome, as complementary either to a
contiguous sequence, positioned in a deﬁned exon or intron, or to a
non-contiguous sequence, corresponding to a deﬁned splice junction.
In the non-contiguous primers, marked with ⁎, bases on the 5′ end are
complementary to bases on the external side of a splice site, whereas
5–6 bases on the 3′ end (shown in italics) are complementary to bases
on the internal side of a splice site.
Ampliﬁcation reactions
For the analysis of viral DNA, an aliquot of the total nucleic acid
fraction, corresponding to 0.05 ml of the cell culture volume, was
directly ampliﬁed. For the analysis of viral RNA, a corresponding
aliquot of the RNA enriched fraction was ﬁrst treated with Turbo
DNAfree reagent (Ambion) and then ampliﬁed. Real-time PCR and RT-
PCR were carried out by using the RotorGene 3000 system (Corbett
Research) and SybrGreen detection of ampliﬁcation products. Ampli-
ﬁcation reactions were performed by using QuantiTect PCR SybrGreen
PCR Kit (Qiagen) or QuantiTect SybrGreen RT-PCR Kit (Qiagen),
including 10 pmol of each speciﬁc primer pair. For PCR, thermal
proﬁle consisted in 15min at 95 °C, then 40 cycles of 15 s at 95 °C, 30 s at
50 °C, and 30 s at 70 °C coupledwith signal acquisition. For RT-PCR, two
parallel reactions were performed for each sample, either including
(RT+) or omitting (RT−) the reverse transcriptase from the reaction
mix, and performing an initial step consisting in 30min at 50 °C, before
the ampliﬁcation reaction with a standard thermal proﬁle. A ﬁnal
melting curvewas performed,with thermal proﬁle ramping from50 °C
to 95 °C at a 12 °C/min rate, coupledwith continuous signal acquisition.
Data analysis
Fluorescence emission was recorded in the FAM/Sybr channel of
the instrument and analyzed by using the functions available in the
177F. Bonvicini et al. / Virology 381 (2008) 168–177RotorGene 6.0 software. Melting analysis was used for the determina-
tion of the speciﬁcity of the ampliﬁcation products by deﬁning, for
each reaction, the melting proﬁle and the Tm of the products; speciﬁc
accumulation of the ampliﬁcation products was also conﬁrmed by
agarose gel electrophoretic analysis. Quantitation of viral DNA and of
total viral RNA was obtained by the absolute quantitation algorithm,
relative to standard targets and normalized to the amount of EC01.
Quantitation of different subsets of viral RNA was obtained by the
comparative quantitation algorithm, calibrated and internally normal-
ized to the amount of total viral RNA.
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